Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae
- PMID: 28381609
- PMCID: PMC5527410
- DOI: 10.1128/JCM.00193-17
Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae
Abstract
The ability of clinical microbiology laboratories to reliably detect carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) is an important element of the effort to prevent and contain the spread of these pathogens and an integral part of antimicrobial stewardship. All existing methods have limitations. A new, straightforward, inexpensive, and specific phenotypic method for the detection of carbapenemase production, the carbapenem inactivation method (CIM), was recently described. Here we describe a two-stage evaluation of a modified carbapenem inactivation method (mCIM), in which tryptic soy broth was substituted for water during the inactivation step and the length of this incubation was extended. A validation study was performed in a single clinical laboratory to determine the accuracy of the mCIM, followed by a nine-laboratory study to verify the reproducibility of these results and define the zone size cutoff that best discriminated between CP-CRE and members of the family Enterobacteriaceae that do not produce carbapenemases. Bacterial isolates previously characterized through whole-genome sequencing or targeted PCR as to the presence or absence of carbapenemase genes were tested for carbapenemase production using the mCIM; isolates with Ambler class A, B, and D carbapenemases, non-CP-CRE isolates, and carbapenem-susceptible isolates were included. The sensitivity of the mCIM observed in the validation study was 99% (95% confidence interval [95% CI], 93% to 100%), and the specificity was 100% (95% CI, 82% to 100%). In the second stage of the study, the range of sensitivities observed across nine laboratories was 93% to 100%, with a mean of 97%; the range of specificities was 97% to 100%, with a mean of 99%. The mCIM was easy to perform and interpret for Enterobacteriaceae, with results in less than 24 h and excellent reproducibility across laboratories.
Keywords: Enterobacteriaceae; antimicrobial susceptibility testing; bacterial antibiotic resistance; bacteriological techniques; carbapenemase; carbapenems.
Copyright © 2017 American Society for Microbiology.
Figures
Comment in
-
Is This the Carbapenemase Test We've Been Waiting for? A Multicenter Evaluation of the Modified Carbapenem Inactivation Method.J Clin Microbiol. 2017 Aug;55(8):2309-2312. doi: 10.1128/JCM.00538-17. Epub 2017 Jun 14. J Clin Microbiol. 2017. PMID: 28615469 Free PMC article.
Similar articles
-
Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii.J Clin Microbiol. 2017 Dec 26;56(1):e01369-17. doi: 10.1128/JCM.01369-17. Print 2018 Jan. J Clin Microbiol. 2017. PMID: 29118172 Free PMC article.
-
Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus.J Clin Microbiol. 2018 Aug 27;56(9):e00137-18. doi: 10.1128/JCM.00137-18. Print 2018 Sep. J Clin Microbiol. 2018. PMID: 29950336 Free PMC article.
-
Comparative Evaluation of Four Phenotypic Methods for Detection of Class A and B Carbapenemase-Producing Enterobacteriaceae in China.J Clin Microbiol. 2018 Jul 26;56(8):e00395-18. doi: 10.1128/JCM.00395-18. Print 2018 Aug. J Clin Microbiol. 2018. PMID: 29769274 Free PMC article.
-
Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae.Expert Rev Anti Infect Ther. 2016 Aug;14(8):705-17. doi: 10.1080/14787210.2016.1206815. Epub 2016 Jul 11. Expert Rev Anti Infect Ther. 2016. PMID: 27348447 Review.
-
Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates.J Clin Microbiol. 2018 Oct 25;56(11):e01140-18. doi: 10.1128/JCM.01140-18. Print 2018 Nov. J Clin Microbiol. 2018. PMID: 30158194 Free PMC article. Review.
Cited by
-
Molecular genotyping reveals multiple carbapenemase genes and unique blaOXA-51-like (oxaAb) alleles among clinically isolated Acinetobacter baumannii from a Philippine tertiary hospital.Trop Med Health. 2024 Sep 26;52(1):62. doi: 10.1186/s41182-024-00629-w. Trop Med Health. 2024. PMID: 39327611 Free PMC article.
-
Diagnostic Test Precision of Modified Carbapenem Inactivation Method and Carbapenemase Nordmann-Poirel Test for Phenotypic Detection of Carbapenemase Production in Enterobacterales: A Systematic Review.Cureus. 2024 Aug 20;16(8):e67322. doi: 10.7759/cureus.67322. eCollection 2024 Aug. Cureus. 2024. PMID: 39301399 Free PMC article. Review.
-
Emergence of high-level aztreonam-avibactam and cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline.JAC Antimicrob Resist. 2024 Sep 5;6(5):dlae141. doi: 10.1093/jacamr/dlae141. eCollection 2024 Oct. JAC Antimicrob Resist. 2024. PMID: 39239090 Free PMC article.
-
Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis.Microbiol Spectr. 2024 Oct 3;12(10):e0296123. doi: 10.1128/spectrum.02961-23. Epub 2024 Aug 28. Microbiol Spectr. 2024. PMID: 39194256 Free PMC article.
-
Carbapenemase producing Enterobacterales at a large teaching hospital in Ohio: comparison to state surveillance and retrospective analysis of patient characteristics.Infect Prev Pract. 2024 Apr 27;6(2):100366. doi: 10.1016/j.infpip.2024.100366. eCollection 2024 Jun. Infect Prev Pract. 2024. PMID: 38765915 Free PMC article.
References
-
- Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA: http://www.cdc.gov/drugresistance/threat-report-2013/.
-
- World Health Organization. 2014. Antimicrobial resistance: global report on surveillance 2014. World Health Organization, Geneva, Switzerland: http://www.who.int/drugresistance/documents/surveillancereport/en/.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous

